These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26970266)

  • 1. Long-term safety and efficacy of armodafinil in bipolar depression: A 6-month open-label extension study.
    Ketter TA; Amchin J; Frye MA; Gross N
    J Affect Disord; 2016 Jun; 197():51-7. PubMed ID: 26970266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of adjunctive armodafinil in adults with major depressive episodes associated with bipolar I disorder: a randomized, double-blind, placebo-controlled, multicenter trial.
    Calabrese JR; Frye MA; Yang R; Ketter TA;
    J Clin Psychiatry; 2014 Oct; 75(10):1054-61. PubMed ID: 25099397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjunctive armodafinil for major depressive episodes associated with bipolar I disorder: a randomized, multicenter, double-blind, placebo-controlled, proof-of-concept study.
    Calabrese JR; Ketter TA; Youakim JM; Tiller JM; Yang R; Frye MA
    J Clin Psychiatry; 2010 Oct; 71(10):1363-70. PubMed ID: 20673554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjunctive armodafinil for major depressive episodes associated with bipolar I disorder.
    Ketter TA; Yang R; Frye MA
    J Affect Disord; 2015 Aug; 181():87-91. PubMed ID: 25933099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The long-term tolerability and efficacy of armodafinil in patients with excessive sleepiness associated with treated obstructive sleep apnea, shift work disorder, or narcolepsy: an open-label extension study.
    Black JE; Hull SG; Tiller J; Yang R; Harsh JR
    J Clin Sleep Med; 2010 Oct; 6(5):458-66. PubMed ID: 20957846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study.
    Vieta E; Owen R; Baudelet C; McQuade RD; Sanchez R; Marcus RN
    Curr Med Res Opin; 2010 Jun; 26(6):1485-96. PubMed ID: 20429835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults.
    Roth T; White D; Schmidt-Nowara W; Wesnes KA; Niebler G; Arora S; Black J
    Clin Ther; 2006 May; 28(5):689-706. PubMed ID: 16861091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Armodafinil for the treatment of excessive sleepiness associated with mild or moderate closed traumatic brain injury: a 12-week, randomized, double-blind study followed by a 12-month open-label extension.
    Menn SJ; Yang R; Lankford A
    J Clin Sleep Med; 2014 Nov; 10(11):1181-91. PubMed ID: 25325609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the potential for pharmacokinetic drug-drug interaction between armodafinil and carbamazepine in healthy adults.
    Darwish M; Bond M; Yang R; Hellriegel ET; Robertson P
    Clin Ther; 2015 Feb; 37(2):325-37. PubMed ID: 25438721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized, placebo-controlled, adjunctive study of armodafinil for bipolar I depression: implications of novel drug design and heterogeneity of concurrent bipolar maintenance treatments.
    Frye MA; Amchin J; Bauer M; Adler C; Yang R; Ketter TA
    Int J Bipolar Disord; 2015 Dec; 3(1):34. PubMed ID: 26330288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modafinil augmentation therapy in unipolar and bipolar depression: a systematic review and meta-analysis of randomized controlled trials.
    Goss AJ; Kaser M; Costafreda SG; Sahakian BJ; Fu CH
    J Clin Psychiatry; 2013 Nov; 74(11):1101-7. PubMed ID: 24330897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Armodafinil for fatigue associated with menopause: an open-label trial.
    Meyer F; Freeman MP; Petrillo L; Barsky M; Galvan T; Kim S; Cohen L; Joffe H
    Menopause; 2016 Feb; 23(2):209-14. PubMed ID: 26125538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maintenance of wakefulness with lisdexamfetamine dimesylate, compared with placebo and armodafinil in healthy adult males undergoing acute sleep loss.
    Gasior M; Freeman J; Zammit G; Donnelly P; Gao J; Ferreira-Cornwell MC; Roth T
    J Clin Psychopharmacol; 2014 Dec; 34(6):690-6. PubMed ID: 25159886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind, placebo-controlled study of armodafinil for excessive sleepiness in patients with treated obstructive sleep apnea and comorbid depression.
    Krystal AD; Harsh JR; Yang R; Rippon GA; Lankford DA
    J Clin Psychiatry; 2010 Jan; 71(1):32-40. PubMed ID: 20051221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The safety and tolerability of cariprazine in patients with manic or mixed episodes associated with bipolar I disorder: A 16-week open-label study.
    Ketter TA; Sachs GS; Durgam S; Lu K; Starace A; Laszlovszky I; Németh G
    J Affect Disord; 2018 Jan; 225():350-356. PubMed ID: 28843918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126).
    Vieta E; Suppes T; Eggens I; Persson I; Paulsson B; Brecher M
    J Affect Disord; 2008 Aug; 109(3):251-63. PubMed ID: 18579216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of shift duration on the efficacy and tolerability of armodafinil in patients with excessive sleepiness associated with shift work disorder.
    Harsh J; Yang R; Hull SG
    Curr Med Res Opin; 2014 May; 30(5):945-51. PubMed ID: 24450538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Armodafinil as adjunctive therapy in adults with cognitive deficits associated with schizophrenia: a 4-week, double-blind, placebo-controlled study.
    Kane JM; D'Souza DC; Patkar AA; Youakim JM; Tiller JM; Yang R; Keefe RS
    J Clin Psychiatry; 2010 Nov; 71(11):1475-81. PubMed ID: 20816042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II double-blind placebo-controlled randomized study of armodafinil for brain radiation-induced fatigue.
    Page BR; Shaw EG; Lu L; Bryant D; Grisell D; Lesser GJ; Monitto DC; Naughton MJ; Rapp SR; Savona SR; Shah S; Case D; Chan MD
    Neuro Oncol; 2015 Oct; 17(10):1393-401. PubMed ID: 25972454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy, Safety, and Tolerability of Armodafinil Therapy for Hypersomnia Associated with Dementia with Lewy Bodies: A Pilot Study.
    Lapid MI; Kuntz KM; Mason SS; Aakre JA; Lundt ES; Kremers W; Allen LA; Drubach DA; Boeve BF
    Dement Geriatr Cogn Disord; 2017; 43(5-6):269-280. PubMed ID: 28448998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.